NCT03039426View on ClinicalTrials.gov

Postoperative Cesarean Delivery Pain Relief; Diclofenac Versus Bupivacaine

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

June 30, 2017

Study Completion Date

December 30, 2017

Conditions
Cesarean Delivery
Interventions
DRUG

Bupivacaine

0.5% bupivacaine 20ml divided in two; 10 ml intraperitoneal infiltration and 10 ml subcutaneous infiltration

DRUG

Diclofenac

diclofenac 75 mg intramuscular, 2 hours postoperation

Trial Locations (2)

10400

Natthida Mekwongtrakarn, Bangkok

Unknown

Rajavithi Hospital, Bangkok

All Listed Sponsors
lead

Department of Medical Services Ministry of Public Health of Thailand

OTHER_GOV

NCT03039426 - Postoperative Cesarean Delivery Pain Relief; Diclofenac Versus Bupivacaine | Biotech Hunter | Biotech Hunter